Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A

general

An acute myeloid leukemia associated with t(9;11)(p21.3;q23.3) and MLLT3-KMT2A fusion protein expression. Morphologically it usually has monocytic features. It may present at any age but it is more commonly seen in children. Patients may present with disseminated intravascular coagulation.

19

Centers

20

Active Trials

$6.0B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A19

Top Centers for Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
—
2
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
—
3
University of Michigan Rogel Cancer CenterAnn Arbor, MI
NCI Comprehensive
—
4
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
—
5
Herbert Irving Comprehensive Cancer CenterNew York, NY
NCI Comprehensive
—
6
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
—
7
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
—
8
Case Comprehensive Cancer CenterCleveland, OH
NCI Comprehensive
—
9
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
—
10
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
—
11
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
—
12
Cleveland Clinic Cancer CenterCleveland, OH
—
13
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
—
14
University of Illinois Cancer CenterChicago, IL
—
15
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
—
16
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
—
17
Cancer Center at IllinoisUrbana, IL
—
18
University of Cincinnati Cancer CenterCincinnati, OH
—
19
Louisiana Cancer Research CenterNew Orleans, LA
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →